Polomar Health Services, Inc. has made significant changes to its board of directors, announcing the resignations of two members, Alexandra Peterson and Gabrielle Toledano. This development reduces the board size from five to three directors, a move that could alter the company's governance and strategic direction.
The resignations were effective October 14, 2026, and were communicated to the board on October 15, 2026. Notably, neither Peterson nor Toledano's departure was attributed to any disagreements regarding the company's operations, policies, or practices.
Background
Polomar Health Services, Inc. operates in the pharmaceutical preparations sector, classified under SIC code 2834. The company is listed on the OTC exchange under the ticker PMHS. Recently, Polomar has been active in filing various forms with the SEC, including a recent 10-Q on August 14, 2026, and multiple 8-K filings throughout the summer.
What the Filing Says
According to the filing dated October 19, 2026, the board of directors has not yet decided whether to fill the vacancies left by Peterson and Toledano or to further reduce the board size. The current board now consists of George Hornig, George Caruolo, and Gabriel Del Virginia.
Impact
This change in leadership may affect the company's governance and strategic initiatives moving forward. Stakeholders, including investors and employees, may be closely monitoring how this reduction in board size influences decision-making processes and overall company direction.
What's Next
The filing does not say what happens next regarding the board vacancies or any potential appointments. Investors and analysts will likely keep an eye on future filings for updates on the board's composition and strategic direction.